Bipolar Disorder News and Research RSS Feed - Bipolar Disorder News and Research

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Symptoms of bipolar disorder are severe. They are different from the normal ups and downs that everyone goes through from time to time. Bipolar disorder symptoms can result in damaged relationships, poor job or school performance, and even suicide. But bipolar disorder can be treated, and people with this illness can lead full and productive lives.
Comorbid OCD not uncommon in bipolar disorder

Comorbid OCD not uncommon in bipolar disorder

Co-occurrence of obsessive compulsive disorder in patients with bipolar disorder type I is not uncommon and is associated with increased functional disability, research findings indicate. [More]
FDA receives Actavis' NDA resubmission for cariprazine

FDA receives Actavis' NDA resubmission for cariprazine

Actavis plc (NYSE: ACT) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Actavis' New Drug Application (NDA) resubmission for its atypical antipsychotic cariprazine, a potent dopamine D3/D2 receptor partial agonist with preferential binding to D3 receptors. [More]
Intriguing small molecule directs activity of key ‘clock proteins’

Intriguing small molecule directs activity of key ‘clock proteins’

In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders. [More]
Offspring of mice treated with drug had delayed onset, reduced symptoms of Huntington's disease

Offspring of mice treated with drug had delayed onset, reduced symptoms of Huntington's disease

Famine, drug abuse and even stress can "silence" certain genes, causing health problems in generations to come. Now scientists are wondering—could therapies that change gene expression in parents help their children? [More]
Multifaceted intervention helps bipolar disorder patients lose weight

Multifaceted intervention helps bipolar disorder patients lose weight

An Integrated Risk Reduction Intervention can help overweight and obese patients with bipolar disorder to reduce their body mass index, US researchers report. [More]
Health promotion program reduces cardiovascular risk in obese people with serious mental illness

Health promotion program reduces cardiovascular risk in obese people with serious mental illness

A health promotion program, called In SHAPE, specifically designed for people with serious mental illness, produced more fit participants and significant weight loss than a control group where participants only received a gym membership. [More]
Psychiatric comorbidities predict bipolar disorder in ADHD children

Psychiatric comorbidities predict bipolar disorder in ADHD children

Children with attention deficit/hyperactivity disorder who also have conduct disorder/oppositional defiant disorder or anxiety disorder are at an increased risk of developing bipolar disorder, research shows. [More]
Bipolar brain changes both state- and trait-dependent

Bipolar brain changes both state- and trait-dependent

Some of the alterations in brain activation in patients with bipolar disorder are dependent on their current mood, study findings show. [More]
Non-use of bipolar medication typically follows careful ‘risk–benefit’ evaluation

Non-use of bipolar medication typically follows careful ‘risk–benefit’ evaluation

An investigation into why and how patients with bipolar disorder manage their moods without medication has found that most individuals are initially motivated by concerns about side effects. [More]
Cerebellar cortical volume reduction specific to schizophrenia

Cerebellar cortical volume reduction specific to schizophrenia

Reduced cerebellar cortical volume occurs only in patients with schizophrenia, rather than all those with psychosis, say researchers. [More]
Quitting cannabis use during manic episodes improves outcomes

Quitting cannabis use during manic episodes improves outcomes

A post-hoc analysis of data from a prospective European study reveals that patients with bipolar disorder who stop using cannabis during a manic or mixed episode have similar clinical and functional outcomes to those who have never used the drug. [More]

UC Berkeley study finds self-worth key to diagnoses of psychopathologies

Donald Trump's ego may be the size of his financial empire, but that doesn't mean he's the picture of mental health. The same can be said about the self-esteem of people who are living from paycheck to paycheck, or unemployed. New research from the University of California, Berkeley, underscores this mind-wallet connection. [More]
New study investigates rate of HIV testing in patients with mental illnesses

New study investigates rate of HIV testing in patients with mental illnesses

People with mental illness are more likely to have been tested for HIV than those without mental illness, according to a new study from a team of researchers at Penn Medicine and the U.S. Centers for Disease Control and Prevention published online this week in AIDS Patient Care and STDs. [More]

Depressive episodes hard to treat in continuous cycling bipolar disorder

Patients with bipolar disorder who switch directly between mania and depression without a period of euthymia have a poor response to short-term antidepressant treatment, study findings indicate. [More]
EMAHSN extends IPS scheme to support people with mental health illness

EMAHSN extends IPS scheme to support people with mental health illness

The 8 December will see the first step in an East Midlands wide approach to supporting people with mental health illness back in to work or education. The East Midlands Academic Health Science Network is championing and extending a widely proven scheme called Individual Placement and Support (IPS) across the region. [More]

Better Care for People with Bipolar Disorder: A new booklet to be launched in December 2014

Bipolar Disorder is in the top 20 causes of years lost due to illness in the world among all health conditions. It affects 1.4% of the population and lasts for the rest of the person’s life. People diagnosed with Bipolar Disorder are 20 times more likely than the general public to commit suicide. In 2007 service provision costs for Bipolar Disorder and related conditions were estimated to be £1.6 billion. This is projected to increase to £2.6 billion by 2026. [More]
Lithium therapy duration not linked to thyroid effects

Lithium therapy duration not linked to thyroid effects

The risk of altered thyroid function does not increase with duration of lithium treatment in patients with bipolar disorder, research suggests. [More]
Researchers uncover easily detectable, 'pre-malignant' state in the blood

Researchers uncover easily detectable, 'pre-malignant' state in the blood

Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and Harvard-affiliated hospitals have uncovered an easily detectable, "pre-malignant" state in the blood that significantly increases the likelihood that an individual will go on to develop blood cancers such as leukemia, lymphoma, or myelodysplastic syndrome. [More]
Study shows how mentally ill women in India go through a vicious cycle

Study shows how mentally ill women in India go through a vicious cycle

An award-winning study by a Loyola University Chicago Stritch School of Medicine researcher has documented how homeless, mentally ill women in India face a vicious cycle [More]
Aequus Pharmaceuticals closes $4.2M private placement offering of special warrants

Aequus Pharmaceuticals closes $4.2M private placement offering of special warrants

Aequus Pharmaceuticals Inc. (the "Company" or "Aequus") is pleased to announce that it has closed a brokered private placement offering (the "Brokered Offering") of special warrants for approximately C$3.7 million. [More]